Enzyme offers hope in MRSA bug battle

An alternative to antibiotics to combat superbugs, such as MRSA, looks promising, according to a leading Irish microbiologist.

A small test study suggests a new drug, an enzyme which solely targets the bacteria in MRSA, was effective against the infection.

Scientists who made the discovery claim the likelihood of the bug becoming resistant was “very limited”. Dutch biotech firm Micreos presented the findings at the EuroSciCon meeting, called Antibiotics Alternatives for the New Millennium, in London yesterday.